BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alkhatry M, Al-Rifai A, Annese V, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani R, Taha MS, Limdi JK. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World J Gastroenterol 2020; 26(43): 6710-6769 [PMID: 33268959 DOI: 10.3748/wjg.v26.i43.6710]
URL: https://www.wjgnet.com/1007-9327/full/v26/i43/6710.htm
Number Citing Articles
1
Gaurav B. Nigam, Kelly Chatten, Ala Sharara, Talal Al-Taweel, Othman Alharbi, Hussein Elamin, Sameer Al Awadhi, Vito Annese, Jimmy K. Limdi. Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle EastTherapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241230902
2
Nana Tang, Han Chen, Ruidong Chen, Wen Tang, Hongjie Zhang. Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn’s disease: a multicenter cohort studyBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02304-y
3
Nana Tang, Han Chen, Ruidong Chen, Wen Tang, Hongjie Zhang. Predicting Mucosal Healing in Crohn’s Disease: A Nomogram Model Developed from a Retrospective CohortJournal of Inflammation Research 2022; : 5515 doi: 10.2147/JIR.S378304
4
I.V. Zhilin, A.A. Zhilina, O.V. Ivanova, I.V. Dianova. Epidemiology of ulcerative colitis in the Zabaykalsky KraiProfilakticheskaya meditsina 2022; 25(8): 42 doi: 10.17116/profmed20222508142
5
Aditi Kumar, Alexander Cole, Jonathan Segal, Philip Smith, Jimmy K. Limdi. A review of the therapeutic management of Crohn’s diseaseTherapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221078456
6
Hala Elzayat, Ghaidaa Mesto, Farah Al-Marzooq. Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel DiseasesNutrients 2023; 15(15): 3377 doi: 10.3390/nu15153377
7
Shokhida Tolkunovna Turdieva. Endoscopic Changes in the Gastrointestinal Tract in Children with HelicobacteriosisBiomedical and Biotechnology Research Journal (BBRJ) 2022; 6(3): 448 doi: 10.4103/bbrj.bbrj_2_22
8
Junya Song, Huihui Zhang, Huihua Zhang, Ximing Xu, Xiaohua Liang, Yongfang Liu, Xiaomei Song, Hong Guo, Xue Zhan, Jinlin Song, Xiaoqin Zhou. The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective studyPediatric Discovery 2024;  doi: 10.1002/pdi3.96
9
Vito Annese, Rahul Nathwani, Maryam Alkhatry, Ahmad Al-Rifai, Sameer Al Awadhi, Filippos Georgopoulos, Ahmad N. Jazzar, Ahmed M. Khassouan, Zaher Koutoubi, Mazen S. Taha, Jimmy K. Limdi. Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab EmiratesTherapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211065329
10
Jimmy K. Limdi. Editorial commentary on the Indian Journal of Gastroenterology November-December 2020Indian Journal of Gastroenterology 2020; 39(6): 527 doi: 10.1007/s12664-020-01140-w
11
Jimmy K Limdi. Editorial commentary on the Indian Journal of Gastroenterology - March-April 2021Indian Journal of Gastroenterology 2021; 40(2): 97 doi: 10.1007/s12664-021-01168-6
12
Ahmed Salman, Mohamed A Salman, Ahmed Elewa, Asmaa M Awwad. Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-AnalysisCureus 2024;  doi: 10.7759/cureus.61547
13
Ahmed El-Sayed, Ceyhun Oztumer, Camellia Richards, Omar-Adam Salim, Mathuri Sivakumar, Laith Alrubaiy. Biologics in Focus: A Comprehensive Review of the Current Biological Therapies for Ulcerative Colitis in the United Arab Emirates (UAE)Gastrointestinal Disorders 2024; 6(1): 241 doi: 10.3390/gidisord6010018
14
Omeed Alipour, Alakh Gualti, Ling Shao, Bing Zhang. Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel diseaseBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01883-6